The study titled “Evidence-based tobacco treatment utilization amongst dual users of cigarettes and e-cigarettes,” measured the frequency of quit attempts during the past year of the study participants. Additionally the researchers, analyzed the use of evidence-based tobacco dependence treatments, such as the nicotine patch, amongst current smokers who also use e-cigarettes and current smokers who don’t.
“With the exception of adults ≥65 years, dual users reported low rates of using combination (behavioral and pharmacological) treatments that were not statistically different from exclusive smokers,” read the study abstract. “Despite higher likelihood for dual users to make a quit attempt, their use of evidence-based tobacco treatment is low, similar to exclusive smokers,” concluded the researchers.
These findings will come as no surprise to many anti-smoking experts, as previous studies have indicated that smokers’ preferred smoking cessation tools are e-cigarettes. This is due to the fact that the action of vaping mimics that of smoking, making the transition from smoking to not smoking an easier one.
E-cigs are smokers’ preferred smoking cessation tools
One such study was released last August and was based on the FDA-funded Population Assessment of Tobacco and Health (PATH). This particular research was carried out to evaluate the effectivity of e-cigarettes and pharmaceutical aids for smoking cessation.
“Our results indicate that [e-cigarettes] are a more popular choice than approved pharmaceutical products as a smoking cessation aid among US quit attempters, over three quarters of whom were daily smokers. In the future, as [vapor] products continue to evolve to make nicotine delivery more similar to that obtained from a cigarette, it is possible that they may play a bigger role in assisting smokers to quit combustible tobacco,” concluded the researchers of the PATH study.